Opus Genetics IRD Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$65.54M-700% | -$16.52M+53.0% | -$17.45M-132% | -$7.42M+4.4% | -$8.19M-15.3% | ||
| $13K0.0% | $13K+30.0% | $13K— | $14K— | $13K— | ||
| $1.46M+60.4% | $774K-2.6% | $816K+5.2% | $896K+11.2% | $913K-7.3% | ||
| -$264K+45.3% | -$921K-154% | -$483K-197% | —— | -$483K-148% | ||
| $1.16M+261% | $804K-47.8% | $906K+353% | -$985K+31.1% | -$718K-707% | ||
| $432K+58.8% | -$873K-137% | -$946K-154% | -$1.95M— | $272K-84.3% | ||
| $2.14M+147% | $973K— | —— | $53K— | $865K+87.6% | ||
| $0+100% | —— | —— | -$1K— | -$1K+90.0% | ||
| -$12.73M-41.5% | -$9.83M-32.2% | -$6.16M-20.0% | -$10.27M-40.8% | -$8.99M-57.3% | ||
| —— | $0-100% | $0-100% | $0-100% | $0-100% | ||
| $0— | $0-100% | $0— | $0— | $0— | ||
| $2.25M+450% | $179K— | $5.22M+1,044% | $0-100% | $409K-83.5% | ||
| $25M— | —— | —— | —— | $0— | ||
| $27.6M+34.8% | $24.11M— | $4.54M+1,187% | $906K-41.2% | $20.47M+761% | ||
| $14.87M+29.6% | $14.28M+326% | —— | —— | $11.47M+443% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $0— | $0— | $0— | $0— | $0— | ||
| —— | $0-100% | $0-100% | $0-100% | $0-100% | ||
| $13K0.0% | $13K+30.0% | $13K— | $14K— | $13K— | ||
| -$51.36M-1,931% | -$5.71M-8,033% | -$9.53M— | $917K— | $2.81M— | ||
| $432K+58.8% | -$873K-137% | -$946K-154% | -$1.95M— | $272K-84.3% | ||
| -$186K+65.2% | -$194K-126% | —— | -$497K-102% | -$534K-151% | ||
| $2.14M+147% | $973K— | —— | $53K— | $865K+87.6% | ||
| —— | $14.25K— | $14.25K— | $14.25K— | $14.25K— | ||
| —— | $0-100% | $0-100% | $0-100% | $0-100% | ||
| $0-100% | —— | —— | —— | $1.37M— | ||
| —— | $98K+113% | $696K+576% | $94K+327% | $1.41M+2,216% | ||
| —— | $5.75M— | $5.75M— | $5.75M— | $5.75M— | ||
| $0-100% | —— | —— | —— | $5.98M— | ||
| $0-100% | —— | —— | —— | $15.52M— | ||
| $33K-8.3% | $116K+214% | —— | —— | $36K-14.3% | ||
| $69K— | $61K— | $68K— | $0— | $0— | ||
| —— | $0-100% | $0-100% | $0-100% | $0-100% | ||
| —— | $263K— | $263K— | $263K— | $263K— | ||
| $0+100% | —— | —— | -$1K— | -$1K+90.0% | ||
| $0— | $0— | $0— | $0— | $0— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Opus Genetics generate?
- Opus Genetics (IRD) generated -$39.0M in operating cash flow over the trailing twelve months.
- Where does Opus Genetics's cash flow data come from?
- Every line is extracted from Opus Genetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
